---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-21-000075"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2021-11-09T23:59:59+00:00"
generated_at: "2026-06-28T10:45:42.290892+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst Q3 revenue beats guidance, adjusted EBITDA loss improves 10%

## Summary
- Total revenue $61.7 million (+31% YoY); technology revenue $38.3 million (+37%) and professional services $23.5 million (+22%).
- GAAP net loss $40 million (vs $27.3 million loss in Q3 2020); operating loss $42.2 million (vs $23.5 million).
- Adjusted EBITDA loss $(5.8) million improved 10% from $(6.4) million loss in prior-year quarter.
- Adjusted technology gross margin 70% (up from 68%); total adjusted gross margin flat at 51%.
- CEO Dan Burton noted strong Q3 performance, exceeding mid-point of guidance for both revenue and adjusted EBITDA.

## SEC filing metadata
- accession: 0001636422-21-000075
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2021-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642221000075/0001636422-21-000075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642221000075/hcat-20211109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-21-000075
- JSON: https://secwatch.observer/filing/0001636422-21-000075.json
- Plain text: https://secwatch.observer/filing/0001636422-21-000075.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.